Literature DB >> 30847461

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?

M Olmedo1, E Reigadas, M Valerio, S Vázquez-Cuesta, J A Pajares, A Matilla, P Muñoz, E Bouza2.   

Abstract

©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Entities:  

Mesh：

Year:  2019        PMID： 30847461      PMCID： PMC6441988     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


  8 in total

Review 1.  Adverse events in faecal microbiota transplant: a review of the literature.

Authors:  M Baxter; A Colville
Journal:  J Hosp Infect       Date:  2015-12-15       Impact factor: 3.926

2.  Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.

Authors:  M Grąt; K M Wronka; M Krasnodębski; Ł Masior; Z Lewandowski; I Kosińska; K Grąt; J Stypułkowski; S Rejowski; M Wasilewicz; M Gałęcka; P Szachta; M Krawczyk
Journal:  Transplant Proc       Date:  2016-06       Impact factor: 1.066

3.  Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.

Authors:  Samuel P Costello; Emily C Tucker; Justin La Brooy; Mark N Schoeman; Jane M Andrews
Journal:  Clin Infect Dis       Date:  2015-11-30       Impact factor: 9.079

4.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.

Authors:  Jasmohan S Bajaj; Zain Kassam; Andrew Fagan; Edith A Gavis; Eric Liu; I Jane Cox; Raffi Kheradman; Douglas Heuman; Jessica Wang; Thomas Gurry; Roger Williams; Masoumeh Sikaroodi; Michael Fuchs; Eric Alm; Binu John; Leroy R Thacker; Antonio Riva; Mark Smith; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

Review 5.  Treating Clostridium difficile infection with fecal microbiota transplantation.

Authors:  Johan S Bakken; Thomas Borody; Lawrence J Brandt; Joel V Brill; Daniel C Demarco; Marc Alaric Franzos; Colleen Kelly; Alexander Khoruts; Thomas Louie; Lawrence P Martinelli; Thomas A Moore; George Russell; Christina Surawicz
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

6.  Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.

Authors:  Elliot Z Smith; Patrick G Northup; Curtis K Argo
Journal:  J Clin Gastroenterol       Date:  2018-09       Impact factor: 3.062

7.  Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections.

Authors:  Marie Hocquart; Jean-Christophe Lagier; Nadim Cassir; Nadia Saidani; Carole Eldin; Jad Kerbaj; Marion Delord; Camille Valles; Philippe Brouqui; Didier Raoult; Matthieu Million
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

Review 8.  Bacterial translocation markers in liver cirrhosis.

Authors:  Alexandra Alexopoulou; Danai Agiasotelli; Larisa E Vasilieva; Spyros P Dourakis
Journal:  Ann Gastroenterol       Date:  2017-07-25
  8 in total
  6 in total

Review 1.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.

Authors:  Kyaw Min Tun; Annie S Hong; Kavita Batra; Yassin Naga; Gordon Ohning
Journal:  Cureus       Date:  2022-05-31

Review 2.  Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review.

Authors:  Yuanbin Liu; Mingkai Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-07

3.  Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies.

Authors:  Lamprinos Michailidis; Alden C Currier; Michelle Le; Deborah R Flomenhoft
Journal:  Ann Gastroenterol       Date:  2021-07-02

Review 4.  Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy.

Authors:  Annie S Hong; Kyaw Min Tun; Jenny M Hong; Kavita Batra; Gordon Ohning
Journal:  Antibiotics (Basel)       Date:  2022-06-23

5.  Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.

Authors:  Yao-Wen Cheng; Dana Alhaffar; Srishti Saha; Sahil Khanna; Matthew Bohm; Emmalee Phelps; Marwan Ghabril; Eric Orman; Sagi Sashidhar; Nicholas Rogers; Huiping Xu; Alexander Khoruts; Byron Vaughn; Dina Kao; Karen Wong; Giovanni Cammarota; Gianluca Ianiro; Tanvi Dhere; Colleen S Kraft; Nirja Mehta; Michael H Woodworth; Jessica R Allegretti; Lotem Nativ; Jenna Marcus; Najwa El-Nachef; Monika Fischer
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-06       Impact factor: 13.576

6.  Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience.

Authors:  M Olmedo; M Kestler; M Valerio; B Padilla; C Rodríguez González; E Chamarro; M Machado; A Álvarez-Uría; L Alcalá; P Muñoz; E Bouza
Journal:  Rev Esp Quimioter       Date:  2022-03-14       Impact factor: 2.515
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.